Tumor cell heterogeneity drives spatial organization of the intratumoral immune response

J Exp Med. 2025 Jun 2;222(6):e20242282. doi: 10.1084/jem.20242282. Epub 2025 Apr 1.

Abstract

Intratumoral heterogeneity (ITH)-defined as genetic and cellular diversity within a tumor-is linked to failure of immunotherapy and an inferior anti-tumor immune response. We modeled heterogeneous tumors comprised of "hot" and "cold" tumor populations (giving rise to T cell-rich and T cell-poor tumors, respectively) and introduced fluorescent labels to enable precise spatial tracking. We found the cold tumor cell population exerted a "dominant cold" effect in mixed tumors. Strikingly, spatial analysis revealed that the tumor cells themselves created distinct local microenvironments within heterogeneous tumors: regions occupied by cold tumor cells showed pronounced immunosuppression, harboring increased CD206Hi macrophages and diminished local T cell function. This inferior T cell activity in cold regions persisted even after immunotherapy and mechanistically was mediated by CX3CL1 produced by the cold tumor cells. An immune cold tumor population within a heterogeneous tumor thus impairs tumor immunity on both a tumor-wide and a highly localized spatial scale.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Chemokine CX3CL1 / immunology
  • Chemokine CX3CL1 / metabolism
  • Humans
  • Immunotherapy
  • Macrophages / immunology
  • Mice
  • Mice, Inbred C57BL
  • Neoplasms* / immunology
  • Neoplasms* / pathology
  • T-Lymphocytes / immunology
  • Tumor Microenvironment* / immunology

Substances

  • Chemokine CX3CL1